In a major boost to the industry, pharmaceutical investments in Mexico reached $600 million this Thursday. International firms AstraZeneca, Bayer, Boehringer Ingelheim, and Carnot made the pledge in the country. These funds arrive after recent investments by Heineken, Walmart, and Netflix. The moves come amid ongoing trade tensions with U.S. Presid…






